Skip to main content
Equibles

AIGH Capital Management LLC

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1835943 BALTIMORE, MD
Back to ZVRA Full portfolio

Position in ZVRA

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$11,183,999
-$531,674 QoQ
Shares Held
1,200,000
-2.6% QoQ
Ownership
2.02%
of shares outstanding
% of Portfolio
2.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
6 quarters on record
Voting authority Sole 73% Shared 27% None 0%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Derivatives in ZVRA

reported options exposure · as of Sep 30, 2025
CallValue
$7,654,290
CallShares
3,221,110
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AIGH Capital Management LLC holds $149,698,985 across 14 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 FENC
Fennec Pharmaceuticals Inc.
 2,486,038 $26,724,908
2 KYTX
Kyverna Therapeutics, Inc.
 2,795,797 $24,910,550
3 ABEO
Abeona Therapeutics Inc.
 2,987,000 $18,459,660
4 ARDX
Ardelyx, Inc.
 3,200,000 $16,319,999
5 SPRB
Spruce Biosciences, Inc.
 250,000 $13,500,000
6 VNDA
Vanda Pharmaceuticals Inc.
 2,044,169 $12,510,313
7 PTHS
Pelthos Therapeutics Inc.
 329,098 $9,300,309
8 PYPD
PolyPid Ltd.
 1,504,741 $7,644,084

All Filings in ZVRA

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,183,999 1,200,000
2025-09-30 $11,715,673 1,231,932
2025-09-30 $7,654,290 3,221,110
2025-06-30 $8,095,446 918,893
2025-03-31 $10,771,435 1,438,109
2024-12-31 $6,577,039 788,614
2024-06-30 $890,197 181,673
2024-06-30 $674,240 137,600